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Abstract
Objective Evaluation of the quantitative accuracy of
MR-based attenuation correction (MRAC) in the Philips
Ingenuity TF whole-body PET/MR.
Materials and methods In 13 patients, PET emission data
from the PET/MR were reconstructed using two different
methods for attenuation correction. In the first reconstruc-
tion, the vendor-provided standard MRAC was used. In the
second reconstruction, a coregistered transmission-based
attenuation map from a second immediately preceding
investigation with a stand-alone Siemens ECAT EXACT
HR? PET scanner was used (TRAC). The two attenuation
maps were compared regarding occurrence of segmenta-
tion artifacts in the MRAC procedure. Standard uptake
values (SUVs) of multiple VOIs (liver, cerebellum, hot
focal structures at various locations in the trunk) were
compared between both reconstructed data sets. Further-
more, a voxel-wise intensity correlation analysis of both
data sets in the lung and trunk was performed.
Results VOI averaged SUV differences between MRAC
and TRAC were as follows (relative differences, mean ±
standard deviation): (?12 ± 6) % cerebellum, (-4 ± 9) %
liver, (-2 ± 11) % hot focal structures. The fitted slopes of
the voxel-wise correlations in the lung and trunk were
0.87 ± 0.17 and 0.95 ± 0.10 with averaged adjusted R2
values of 0.96 and 0.98, respectively. These figures include
two instances with partially erroneous lung segmentation
due to artifacts in the underlying MR images.
Conclusion The MR-based attenuation correction
implemented on the Philips Ingenuity PET/MR provides
reasonable quantitative accuracy. On average, deviations
from TRAC-based results are small (on the order of
10 % or below) across the trunk, but due to interindi-
vidual variability of the segmentation quality, deviations
of more than 20 % can occur. Future improvement of the
segmentation quality would help to increase the quanti-
tation accuracy further and to reduce the inter-subject
variability.
Keywords PET/MR  MR-based attenuation correction 
PET quantification
Introduction
The recent introduction of dedicated clinical whole-body
PET/MR systems by [1] and Siemens Healthcare [2] rep-
resents an important milestone in the development of
combined PET/MR imaging. First systems were installed
during 2010 by Philips and Siemens and reached CE
approval in 2011.
As discussed, e.g., in Refs. [3–9], the prospects of
combined PET/MR in bimodal functional imaging are huge
in various clinical fields, notably in oncology, neurology,
and cardiology. Compared to PET/CT, PET/MR profits
from the superior soft tissue contrast of MRI and offers the
option of combining functional PET and MR imaging
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techniques which go well beyond what is possible with
PET/CT [6, 9]. A further obvious advantage is the lack of
radiation exposure in MRI examinations.
The actual combination of PET and MRI faced many
challenges [6, 9]. One major obstacle was the mutual
adverse effects of the PET and MRI hardware and data
acquisition/processing electronics and the magnetic field
intolerance of the photomultipliers. Philips and Siemens
solved these problems by developing the sequential Inge-
nuity TF PET/MR and the integrated BiographTMmMR
PET/MR, respectively. The former system, which was
installed at our institute in the fall of 2010, employs
established PET and MR technology with suitable modi-
fications while the latter system relies on new detector
technology for the PET component.
Another major challenge, which affects all current
PET/MR designs equally, is the development of a reliable
MR-based attenuation correction (MRAC) for PET image
reconstruction. Attenuation correction (AC) is mandatory
in order to obtain correct regional PET image contrast and
to enable quantitative assessment of regional tracer con-
centrations and derived parameters such as standard uptake
values (SUVs) or tracer kinetic parameters.
Commonly, AC in PET is based on one of the following
two methods:
(a) In stand-alone PET systems, AC is based on a direct
measurement of photon attenuation by performing a
separate transmission scan (TRAC). For this purpose,
one or more suitable radioactive sources are rotated
around the body. Based on this measurement and a
blank scan the transmitted photon fraction is deter-
mined and may be directly used for AC. In the case of
whole-body PET measurements with the Siemens
ECAT EXACT HR?-scanner the AC factors are used
to reconstruct a tomographic image of the 511-keV
attenuation coefficients. A forward projection of the
weighted sum of the reconstructed image itself and a
segmented version is finally used for AC [10–13].
(b) In today’s PET/CT systems, radioactive sources are
no longer available. Instead, AC is based on a CT
scan. The required transmission map is obtained by
bilinear scaling of Hounsfield units [14, 15].
In PET/MR, however, where neither a CT nor a trans-
mission source is available, a different strategy must be
used. Hofmann et al. [16] discussed several approaches to
MRAC including:
(a) intensity-based tissue type segmentation and classifi-
cation of an MR image [17–20]
(b) atlas-based segmentation techniques [21, 22]
both followed by an assignment of the respective attenu-
ation coefficients according to the tissue type.
Currently, both commercially available whole-body
PET/MR systems implement MRAC based on approach
(A). While both systems provide attenuation corrected PET
images with plausible regional contrast and quantitative
parameters such as SUVs, a thorough in vivo evaluation
and validation is missing up to now.
Several groups have already investigated the quantita-
tive influence of segmented attenuation maps on recon-
structed PET data. Refs. [19] and [23] used segmented
attenuation maps based on CT scans and purely simulated
data, respectively, whereas Refs. [17, 20, 24] compared
data from PET/CT investigations and MRAC reconstruc-
tions of several patients where MR-based attenuation maps
(MRmaps) were derived from aligned MR scans performed
in addition to PET/CT scans. However, no work exists
comparing MRAC to TRAC which can be considered the
de facto gold standard for attenuation correction. Thus, the
aim of our investigation is the evaluation of the quantita-
tive accuracy of MRAC as currently implemented in the
Ingenuity PET/MR [17, 20] by a comparison to TRAC.
Materials and methods
Data acquisition
In our analysis, we investigated 13 patients who first
underwent examination with the stand-alone ECAT
EXACT HR? [25] PET scanner (Siemens, Erlangen, Ger-
many) and, subsequently, a second examination with the
Ingenuity TF PET/MR (Philips, Cleveland, US). Details of
patient demographics are shown in Table 1. For patients
1–9 a whole-body PET protocol was used, whereas patients
10–13 were examined with a head-neck PET protocol. In
the two successive PET scans, care was taken to ensure
comparable positioning of the patient and to cover a similar
axial field of view (FOV).
The first scan was carried out with the HR? stand-alone
PET which permits transmission measurements at 511 keV
using rotating 68Ge/68Ga rod sources. The second scan was
conducted in the Ingenuity TF PET/MR which combines a
modified Philips Gemini TOF PET with a 3 T Achieva MR.
The performance of the system components is essentially
identical to what is known from the corresponding PET/CT
and stand-alone Achieva MR systems [1].
Depending on body weight, the patients were injected
between 288 and 372 MBq 18F-FDG. After an uptake
period of 60 min all patients underwent a routine clinical
18F-FDG scan in the HR?. In all cases, the acquisition time
of the transmission scan was 4 min per bed position. All
examinations took place with arms-down and in free-
breathing mode. To improve patient comfort, cushions and
pillows were positioned below the head and knees of the
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patients. After completion of the first examination all
patients left the patient bed and stayed in a waiting room
for about 60 min. Subsequently, they underwent the
PET/MR examination which started, on average, about
180 min p.i. and consisted of:
1. a fast 3D T1-weighted gradient-echo MR sequence
(atMR) used for MRmap computation,
2. the PET emission acquisition, and
3. (optional) diagnostic MR sequences.
Throughout the entire examination the patients remained
in a fixed position on the patient bed which was moved
automatically between the MR and PET gantries. The
parameters of the atMR scan were: flip angle 10, TE
2.3 ms ,TR 4 ms, minimal water-fat shift, no water or fat
saturation and voxel size 3 mm 9 3 mm 9 6 mm. 12 cm
3D stacks were acquired with 12 mm overlap covering a
total transaxial FOV of 60 cm. The acquisition time per
stack was 16 s. In all cases, the Q-Body coil was used for
the atMR image acquisition. For the head-neck investiga-
tions, an NV 16 head-neck coil was additionally connected
but only used for acquisition of diagnostic MR sequences
following the PET scan. Again, all patients were examined
in arms-down and free-breathing mode.
Subsequent to the atMR, PET emission data were
acquired for 2 min and 6 min per bed position in the
whole-body and head-neck investigations, respectively.
Image reconstruction
Figure 1 shows the work-flow of our analysis consisting of
two separate reconstructions of the PET/MR emission data.
First, we executed the vendor-provided standard MRAC
reconstruction, shown in the top branch. The MRmap is
derived by tissue type segmentation and classification of
the atMR images acquired in the atMR sequence (MRmap
conversion) [17, 20]. The conversion algorithm segments
the atMR image into air, lung and soft tissue, adjusts the
spatial resolution (Gaussian filter, 6 mm FWHM), and
assigns linear attenuation coefficients of 0, 0.022, and
0.096 cm-1, respectively. For both types of protocols
(whole-body and head-neck), the MRmap conversion
algorithm works in the same way. The result of the stan-
dard reconstruction using MRAC is a first PET image
volume called PETMRAC in the following.
As shown in the lower branch of Fig. 1, we performed a
second reconstruction of the PET/MR emission data using
the transmission scans from the HR? examinations as
external information about photon attenuation (TRAC).
For this purpose, we first removed information about
attenuation of all structural materials (bed and coils) from
the TRmaps and MRmaps. In case of the TRmaps, this was
done by subtracting a separate transmission scan of the
HR? bed. In the MRmaps we removed the existing (ven-
dor-provided) attenuation templates for patient bed and
respective coils.
Secondly, we coregistered the obtained TRmaps to the
corresponding MRmaps. Coregistration was performed
with the software ROVER (ABX GmbH, Radeberg, Ger-
many) using a rigid transformation to maximize the mutual
information between both data sets [26]. Since the head
and leg supports are rather different in the HR? and
PET/MR systems, these parts of the image volumes were
excluded from the rigid coregistration. In the cases of the
head-neck investigations automatic coregistration of the
heads did not work because of the different inclination of
Table 1 Patient demographics












1 Lymphoma F 51 168/75 301 60/120 WB/WB 6
2 Tonsil Ca M 62 167/55 372 65/225 WB/WB 4
3 Lymphoma M 55 167/72 348 65/160 WB/WB 4
4 Lymphoma M 71 164/60 288 60/170 WB/WB 4
5 Lymphoma M 27 183/72 354 90/185 WB/WB 8
6 Sarcoma M 44 176/82 364 55/180 WB/WB 6
7 Lung Ca M 55 189/93 350 70/210 WB/WB 6
8 Lymphoma F 28 163/67 320 60/160 WB/WB 4
9 Head-neck Ca M 60 170/68 345 70/180 WB/WB 6
10 Squamous cell Ca M 78 163/81 328 50/170 WB/HN 0
11 Squamous cell Ca F 82 160/75 363 55/165 WB/HN 0
12 Squamous cell Ca F 79 146/43 292 60/170 WB/HN 0
13 Squamous cell Ca M 73 168/65 332 135/205 WB/HN 0
Whole-body (WB) and head-neck (HN) PET protocols were used for examination
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the head/neck relative to the thorax. Instead, we manually
coregistered the brain region of the HR? PET image to the
corresponding region in the atMR image volume. Subse-
quently, we applied the resulting rigid transformation to the
transmission-based attenuation map of the HR?. Correct
alignment relative to the atMR was finally double-checked
by a further visual inspection.
After conversion of the attenuation maps to the pro-
prietary Philips ‘‘.img’’ file format, templates for patient
bed and the respective coils were added to the TRmaps.
The PET image volume resulting from this second recon-
struction will be called PETTRAC in the following. In the
absence of possible errors caused by residual registration
mismatch between the TRmap and the emission data set,
we consider PETTRAC as the de facto gold standard against
which the PETMRAC data set can be evaluated.
Image analysis
For the analysis we first outlined a number of 3D regions
(volumes of interest: VOIs) in PETMRAC and PETTRAC for
which individual voxel values as well as summary
parameters were compared.
In the whole-body data sets we manually placed VOIs in
the liver and the lung. Additionally several hot focal
structures above the liver were delineated using the auto-
matic VOI delineation method implemented in the ROVER
software [27] (ABX, Radeberg, Germany) which uses
adaptive thresholding for volumetrically correct VOI
determination [28]. The body region below the liver was
excluded from the comparison because of possible signif-
icant peristaltic movement between the two examinations.
In the head-neck investigations, we placed a single VOI in
the cerebellum. Examples for all VOIs, except for the hot
focal structures, are shown in Fig. 2.
In the liver, cerebellum and hot focal structure VOIs we
investigated the absolute and relative differences




of the SUVs between the two PET image volumes. In each
VOI, the deviation of the maximum (DSUVmax) and the
mean values (DSUVmean) was determined.
We furthermore performed a linear regression analysis
of the SUV correlation for all voxels in the complete lung
and trunk (see Fig. 2). VOI delineation was performed
using manual thresholding in the atMR images (lung) and
PET images (trunk), respectively. A straight line through
the origin was fitted to the voxel data according to
SUVMRAC ¼ m  SUVTRAC: ð3Þ
The goodness of fit was assessed using adjusted
R2-values.
Results
Visual comparison of the attenuation maps
and reconstructed PET volumes
Figure 3 shows corresponding coronal slices of the atMR
image, the MRmap and the TRmap of patients 1 and 6.
Truncation artifacts in the atMR and MRmap are clearly
visible. These artifacts are caused by the reduced trans-
axial FOV of the MR which is approximately 15 cm
smaller than that of the PET scanner. A vendor-provided
protocol for compensation of truncation artifacts based on a
segmentation of a non-attenuation-corrected PET image
exists which works reasonably well in general but imper-
fectly in selected cases. Therefore, and because the trun-
cation compensation option is not used in our clinical
routine, we did not use it in the present investigation.
In the two whole-body investigations shown in Fig. 3
we also observed that lung segmentation in the atMR did
Fig. 1 Scheme of the two reconstructions of the PET/MR emission data using MR-based attenuation correction and an external transmission-
based attenuation correction. Further details are given in the text
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not work properly. One case (top row) shows abnormally
low signal intensity in the areas below both lungs which
leads to an erroneously segmented lung extending too far in
the caudal direction. In the second case (bottom row), lung
segmentation failed more severely when using the default
parameter settings of the segmentation procedure. In this
case, the MRmap shows several small cavities erroneously
identified as air rather than lung tissue. The reason for this
segmentation failure is the presence of pronounced heart
motion artifacts in the atMR. The decreased image contrast
between lung and soft tissue regions leads to the observed
misinterpretation of the atMR by the conversion algorithm.
In Fig. 3g the segmentation was repeated with different
parameter settings which shows that segmentation failure
Fig. 2 Representative transaxial (a), coronal (b) and sagittal (c) views of VOI definition in liver (1), lung (2), trunk (3) and cerebellum (4)
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can be avoided by adjusting the relevant parameters of the
algorithm. Since our intention was the evaluation of the
current default MRAC procedure the erroneous segmen-
tation (e) was used in our further analysis.
Figure 4 shows corresponding coronal PETMRAC and
PETTRAC slices as well as the resulting absolute and rela-
tive SUV differences for patient 1. Rather large negative
deviations are found in the liver dome and the spleen.
Large positive deviations are observed along the arms,
which are due to the slightly different positioning of the
arms during the PET and PET/MR examinations.
Figure 5 shows the same quantities as Fig. 4 for patient
11 (head-neck investigation). A pronounced relative
increase of SUVMRAC can be seen in the face and neck
contour (up to ?100 %) and in the nasal cavities (?40 %).
The former one results from an imperfect alignment of the
MRmap and TRmap, whereas the latter is due to the non-
segmentation of the air-filled nasal cavities.
Comparison of reconstructed SUVs in different VOIs
Figure 6 and Table 2 show and summarize the absolute
and relative SUV differences between PETMRAC and
PETTRAC calculated according to Eqs. (1) and (2) in the
liver, cerebellum, and hot focal structure VOIs, respec-
tively. Only patients 4 and 7 exhibit SUVmax deviations
above 10 % in the liver VOI. These data sets show dis-
crepancies regarding the axial extension of the lung
between MRmaps and TRmaps (larger in the MRmaps).
In the four head-neck investigations, a systematic
overestimation of the SUVmax of 12 % is observed.
In the analysis of the 49 hot focal structures, we found a
mean SUVmax deviation of -2 % with a standard deviation
of 11 %. The maximum overestimation was 22 % in brown
fatty tissue supraclavicular near the body surface and the
maximum underestimation was -17 % in a lesion near the
lung boundary.
Voxel-by-voxel correlation analysis
Figures 7 and 8 display the voxel intensity (SUV) corre-
lation between PETMRAC and PETTRAC in the lungs and in
the trunk of patients 1–9, respectively. The results of the
fitted slopes are summarized in Table 3. Except in one
case, PETMRAC yields lower values in the lung than
PETTRAC. In patient 6, the SUVMRAC is higher than
SUVTRAC while the degree of linear correlation is
decreased, exhibiting a rather low adjusted R2 of 0.93. As
shown in Fig. 3e, these discrepancies are caused by an
incorrect lung segmentation in the MRmap generation. By
comparing the attenuation coefficients of the lung in both
attenuation maps, we found that the assigned value in the
MRmaps is approximately 10 % lower than the measured
one in the TRmaps. As observed in the lung, SUVMRAC in
the trunk is on average lower than SUVTRAC for most
patients (with the notable exception of patient 6). However,
the bias is distinctly smaller than in the lung alone.
Discussion
In general, the vendor implementation of MRAC for the
Ingenuity PET/MR system assuming a 3-class tissue sep-
aration (air, lung and soft tissue) provides reasonable
accuracy with respect to SUV-based quantification. The
MRAC corrected PET emission data are quantitatively in
Fig. 3 Two instances of incorrect lung segmentation. Corresponding
slices of atMR (left), MRmap (middle), and TRmap (right) are shown
for patient 1 (a–c) and 6 (d–f), respectively. The inset (g) displays the
much improved lung segmentation in the latter patient after adjusting
the relevant parameter of the segmentation algorithm
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agreement with those obtained using TRAC for the same
PET emission data within an error margin of about
10–20 % as shown in Fig. 6b and Table 2. However, the
exact magnitude of the local deviations between MRAC
and TRAC is dependent on the investigated patient and of
course also organ specific. The same holds true for the
influence of potential segmentation errors (which mostly
concern the lung and its vicinity).
In the cerebellum VOIs, we observed a small systematic
difference of 12 % between PETMRAC and PETTRAC, while
Fig. 4 Corresponding coronal PETMRAC (a) and PETTRAC (b) slices
of patient 1. The absolute and relative SUV differences according to
Eqs. (1) and (2) are shown in (c) and (d), respectively. In order to
improve visibility of the relevant differences, some spurious voxels in
the left arm are suppressed in image (d) by choosing a suitable upper
threshold
Fig. 5 Same as Fig. 4 for a sagittal slice of patient 11. In order to
improve visibility of the relevant differences, some spurious voxels in
the chin are suppressed in image (d) by choosing a suitable upper
threshold. Subfigures (e) and (f) show the corresponding slices of the
MRmap and TRmap, respectively
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otherwise the average differences remained insignificant
(i.e. were much smaller than the inter-subject variability).
The probable explanation of the observed SUV bias in
the cerebellum is the fact that the air space in the nasal
cavity is erroneously treated as soft tissue by the MRAC
algorithm. Hence, the attenuation for emission events
detected along lines of response crossing the cerebellum
and the oral and nasal cavities is overestimated leading to
an overcorrection and artificial increase in the recon-
structed SUVs in the transaxial planes around the cavities.
As the small observed inter-subject variability (4 %)
demonstrates, this effect is fairly constant across patients.
In the other investigated regions, the inter-subject vari-
ability of the observed differences is modest and amounts
to a standard deviation of 10 percentage points in the liver
and in the different hot focal structures. The total range of
observed deviations exceeds 20 % only in one case.
Closer inspection of the most pronounced deviations
revealed that the corresponding VOIs are located at tissue
borders (e.g. at the lung border) where linear attenuation
coefficients in the MRmaps and TRmaps are not com-
pletely concordant due to their different resolution. The
observed deviations in these cases are thus at least partly
due to the mismatch between the spatial resolution of
the external TRmap (ca. 10 mm) and of the MRmap
(ca. 6 mm).
In patient 7, where we found the maximum SUV devi-
ation in the liver VOI (-18 %), we observed a larger
anterior-posterior extension of the segmented lung in the
MRmap than in the TRmap. After manual editing the
MRmap, enforcing concordance with the lung extension in
the TRmap, the SUV difference dropped to -10 %. The
larger anterior-posterior extension can be explained by the
different positioning of the legs which can cause different
positions of the lumbar spine and the diaphragm in both
scans.
The voxel-based intensity correlation analysis shown in
Figs. 7 and 8 and Table 3 demonstrates a satisfactory linear
Fig. 6 Absolute (top) and relative (bottom) SUV differences between
PETMRAC and PETTRAC in the liver (1), the cerebellum (2), and
several hot focal structures (3) located in the lung and mediastinum
(red), in the thoracic spine (blue), in the liver and kidneys (orange)
and in the clavicular region (black), respectively. Crosses indicate
SUVmax, circles SUVmean deviations in the respective VOIs. The
horizontal dashed lines show ±10 % deviations. The boxplots in the
right margins of the plots represent the resulting distributions of
the respective SUVmean deviations
Table 2 Relative differences (mean ± standard deviation) between SUVMRAC and SUVTRAC in the liver, the cerebellum and several hot focal
structure VOIs
VOI number DSUVrel;max [%] DSUVrel;mean [%]
Mean ± SD Median Range Mean ± SD Median Range
Liver 9 -4 ± 9 -5 -18 to 8 -5 ± 10 -7 -20 to 12
Cerebellum 4 12 ± 6 12 6 to 19 12 ± 4 12 8 to 17
Hot focal structures
Total 49 -2 ± 11 -6 -17 to 22 -1 ± 10 -4 -16 to 23
Lung and mediastinum 8 -13 ± 3 -14 -17 to -9 -13 ± 3 -14 -16 to -8
Thoracic spine 18 -6 ± 8 -8 -16 to 19 -5 ± 7 -6 -12 to 15
Clavicular region 18 7 ± 9 7 -13 to 2 7 ± 8 6 -11 to 2
Liver and kidney 5 -1 ± 6 -1 -8 to 9 -1 ± 6 -2 -6 to 9
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correlation between the SUVs from PETMRAC and
PETTRAC data. However, as can be seen in Fig. 7, the
SUVs in the lung are systematically underestimated in
PETMRAC. A similar systematic deviation of the recon-
structed SUVs is observed in the analyzed hot focal
structure VOIs located in the lung and the mediastinum
(see Fig. 6; Table 2). This observation can be explained by
taking into account that the attenuation coefficient assigned
to lung tissue in the MRmaps is about 10 % lower than the
corresponding value in the TRmaps. A corresponding
increase of this value would lead to a decrease or removal
of the currently observed systematic underestimate. We
presume that the ultimate cause of this apparently incorrect
attenuation coefficient are residual uncertainties involved
in the rescaling of Hounsfield units in CT-based attenuation
measurements to 511 keV [15, 29].
Regarding the whole trunk (including the lung) we
observed only a very small average reduction of SUVMRAC
versus SUVTRAC (see Fig. 8; Table 3), which is presum-
ably due to the contribution from lung voxels to the cor-
relation. More important, the inter-subject variability
amounts to a standard deviation of 10 percentage points
and a range from -18 to ?13 percentage points regarding
the slope of the best straight line fit through the origin. This
translates into corresponding uncertainties to be expected
for reasonably sized VOIs in this body region.
Overall, our findings are consistent with earlier evalua-
tions of segmented AC for PET as presented in Refs.
[19, 23]. However, this is the first study comparing the
performance of MRAC directly against a transmission
measurement at the relevant photon energy of 511 keV.
While the usability of CT-based attenuation correction for
quantitative PET is unquestionable, it is well known that
this approach has certain limitations and weaknesses
stemming from residual uncertainties in the correct rescal-
ing of Hounsfield units [29], resolution mismatch between
PET and CT and its handling, and motion artifacts [30].
Transmission measurements with radioactive sources have
different issues, notably the reduced statistical accuracy and
low resolution of the measurements but do not suffer from
most of the other problems of CT-based attenuation cor-
rection. Therefore, we consider transmission measurements
still as the most accurate available option for attenuation
correction in PET. Our results are thus complementary to
those obtained previously in previous MRAC evaluations
against CT-based attenuation correction.
Fig. 7 Voxel intensity (SUV) correlation between PETMRAC and
PETTRAC in the lungs of patients 1–9. The correlations are displayed
as 2D histograms of 50 9 50 bins with color-coded frequencies. The
dashed line indicates the line of identity, the solid line represents the
best fit of Eq. (3) to the data. The adjusted R2 and slope m of the fitted
straight line through the origin are specified in the plots
Magn Reson Mater Phy (2013) 26:115–126 123
123
Our study, nevertheless, has certain limitations which
should be considered. The main drawback of our method is
the fact that the transmission measurement was performed
in a different system, requiring repositioning of the patients
in the PET/MR. Consequently, proper coregistration of
both attenuation maps is not guaranteed and has to be
performed by suitable means. Since the positioning of the
arms, legs, and—especially—of the head was slightly dif-
ferent in both PET systems because of different patient
beds, head rests and cushions), a rigid transformation is not
sufficient for coregistration of the whole data sets. Coreg-
istration therefore was performed independently for the
trunk and the head neck area of the image volumes. Minor
residual coregistration mismatch persisted nevertheless to
some extent, e.g. in the arms. Moreover, the fact that the
patients did not stay on the same patient bed and that a
certain time elapsed between both scans implies the pos-
sibility of organ movement in the abdomen which would
not be accounted for completely by the coregistration. For
instance, as observed in three cases, differences in the
shape of the lumbar spine caused by the use of leg cushions
caused a small displacement of the diaphragm leading to
different expansions of the lung in the caudal direction
during the examinations. While we visually verified that
quality of the coregistration was satisfactory, residual
mismatch can be expected to exist and contribute to part of
the observed differences. However, since regional variation
of the attenuation coefficient in the abdomen is rather small
(and good coregistration of the lungs is easy to achieve and
verify) we do not expect that coregistration mismatch is a
source of serious error in this study.
Another limitation is the lower spatial resolution of the
TRmaps compared to the MRmaps. This might cause
artifacts at tissue boundaries as seen to some extent at the
boundaries of the lungs. Moreover, the segmentation pro-
cess of the TRmaps used in the whole-body protocols of
the HR?-scanner to reduce noise lowers the attenuation
coefficients of structures with high attenuation values such
as bone. However, as shown in [11] the difference in the
quantitative accuracy between segmented and non-seg-
mented TRAC is small.
Fig. 8 Same as Fig. 7 for all voxels in the trunk of patients 1–9
Table 3 Results for the slope m (mean ± standard deviation) and the
averaged adjusted R2-value of the correlation analysis between
SUVMRAC and SUVTRAC in the lung and trunk according to Eq. (3)
VOI fitted slope m of correlation R2
mean ± SD median range mean
Lung 0.87 ± 0.17 0.82 0.71–1.27 0.96
Trunk 0.95 ± 0.10 0.92 0.82–1.13 0.98
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A further limitation of this study is the fact that trun-
cation artifacts were not corrected for in order to replicate
our standard clinical protocols. As explained in the
methods section the aim of this study was the evaluation
of the vendor-provided standard procedure which currently
does not use the optional truncation compensation. Hence,
the observed underestimation of the SUVs in the trunk and
lung includes the underestimation caused by the truncation
and, thus, can be considered as a worst case estimation. In
order to estimate the quantitative influence of truncation
artifacts on the reconstructed SUVs, we performed an
additional reconstruction of patient 3, where we manually
corrected the attenuation coefficients in the truncated arms
in the MRmap. In comparison with the PET volume
reconstructed with the truncated MRmap, we found that
80 % of the voxels in the trunk showed deviations of less
than ± 5 % with an average deviation of -3 %. Since the
size of truncated areas in all patients of this study was
approximately the same, similar deviations can be
expected in the other cases. Thus, the influence of the
truncation artifacts on the reconstructed SUVs is far less
serious than erroneous lung segmentation. Nevertheless,
automated truncation compensation is desirable and one of
the fields where improvements can be expected in the near
future.
Conclusion
The MR-based attenuation correction implemented on the
Philips Ingenuity PET/MR provides reasonable quantita-
tive accuracy which is in accordance with transmission-
based attenuation correction within an error margin of
about 10–20 %. There is some room for improvement
regarding the MR sequences and the segmentation algo-
rithm used, whose sporadic partial failure currently is
responsible for most observed deviations above 10 %.
Currently, segmentation results should be verified in each
patient investigation in order to eliminate this source of
quantitation error. A further issue is the observed bias in
lung SUVs of 13 % on average, which is caused by the
value used for the linear attenuation coefficient in the lung.
Suitability of this value should be reconsidered. Despite the
present limitations, we consider the investigated MRAC
algorithm adequate for the usual quantitation tasks in
whole-body PET.
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